Restabilization of chronic inflammatory demyelinating polyneuropathy patients with IVIG: restabilization phase of the PATH study
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Incidence of GBS and CIDP Following Influenza Vaccination
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Wear-Off in IVIG and What it Means in Clinical Practice
Electrophysiologic Findings In Multifocal Motor Neuropathy
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Therapy
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second Revision
IgG Levels and Wear Off Reflect Administration and Outcome
Fatigue in CIDP
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength Measurements
GBS and Zika Virus
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
CIDP Assessment Tools: Grip Strength
SCIg in Multifocal Motor Neuropathy
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Restabilization of chronic inflammatory demyelinating polyneuropathy patients with IVIG: restabilization phase of the PATH study
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Incidence of GBS and CIDP Following Influenza Vaccination
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Wear-Off in IVIG and What it Means in Clinical Practice
Electrophysiologic Findings In Multifocal Motor Neuropathy
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Therapy
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second Revision
IgG Levels and Wear Off Reflect Administration and Outcome
Fatigue in CIDP
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength Measurements
GBS and Zika Virus
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
CIDP Assessment Tools: Grip Strength
SCIg in Multifocal Motor Neuropathy
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.